BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

Overview Fund Activity

27 hedge funds and large institutions have $36.3M invested in ProShares Ultra NASDAQ Biotechnology in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
-1
Holders Change %
-3.57%
% of All Funds
0.73%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
4
Increased
7
Reduced
11
Closed
5
Calls
$14.2M
Puts
$38.2M
Net Calls
-$24M
Net Calls Change
-$1.52M

Top Buyers

1
Creative Planning
1
Creative Planning
Kansas
$2.25M
2
OPPM
2
Opus Point Partners Management
New York
$4.84M
3
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
$1.42M
4
Citadel Advisors
4
Citadel Advisors
Florida
$4.93M
5
VKH
5
Virtu KCG Holdings
New York
$591K

Top Sellers

1
Jane Street
1
Jane Street
New York
$664K
2
VCAM
2
Valentine Capital Asset Management
California
$5.33M
3
TRCT
3
Tower Research Capital (TRC)
New York
$754K
4
Morgan Stanley
4
Morgan Stanley
New York
$637K
5
SG Americas Securities
5
SG Americas Securities
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
WA
26
Waverly Advisors
Alabama
$5K – – –
SG Americas Securities
27
SG Americas Securities
New York
– -$650K -8,200 Closed
HighTower Advisors
28
HighTower Advisors
Illinois
– -$484K -6,108 Closed
UBS Group
29
UBS Group
Switzerland
– -$294K -3,716 Closed
PFG
30
Piershale Financial Group
Illinois
– -$2K -28 Closed
TCM
31
Tradewinds Capital Management
Washington
– -$2K -20 Closed
1
2